circRNA-MYLK was found to activate vascular endothelial growth factor A (VEGFA) through acting as a sponge of miR-29a, thereby promoting tumor growth, metastasis, and angiogenesis of bladder cancer [12]. Here, VEGFA is linked to urinary bladder carcinoma.